Clinical trial
Real-word Study of the de NOVO Use of Once-daily Extended-release tacrolimuS (LCPT) in Kidney Transplantation Using an ARTificial Intelligence Prognostic System: a Multicenter Prospective Ob-servational Study
NCT06960824 is registered in ClinicalTrials.gov with Chiesi SAS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-word Study of the de NOVO Use of Once-daily Extended-release tacrolimuS (LCPT) in Kidney Transplantation Using an ARTificial Intelligence Prognostic System: a Multicenter Prospective Ob-servational Study
- Lead sponsor
- Chiesi SAS
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 31, 2025
- Completion date
- December 31, 2027
- Enrollment
- 165 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic renal disease